Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05169424 · ClinicalTrials.gov registry record
A Study in the US Based on Pharmacy and Medical Claims That Compares How Well Stiolto® and Trelegy® Work in People With Chronic Obstructive Pulmonary Disease (COPD)
A clinical trial, sponsored by Boehringer Ingelheim.
- Completed
- Registry status
- 9,117
- Enrollment target
NCT05169424: Completed study, sponsored by Boehringer Ingelheim.
NCT05169424 is a clinical trial that has completed, run by Boehringer Ingelheim. The registered enrollment target is 9,117 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05169424 has completed, sponsored by Boehringer Ingelheim.
- COMPLETED
- Registry status
- 9,117 participants
- Enrollment target
Study Summary
This study looks at data from people with chronic obstructive pulmonary disease (COPD). Some used Stiolto Respimat and the others Trelegy Ellipta as their first treatment for COPD. The purpose of this study is to find out how well the treatments worked. Researchers compare the time to first COPD flare-up (exacerbation) between the 2 treatments. The study analyses anonymous data from pharmacy claims collected over 3.5 years.
Primary Outcome
Incidence rate of chronic obstructive pulmonary disease (COPD) exacerbation after cohort entry were reported. The incidence rate was calculated as totaling the number of exacerbation for all patients / total follow-up in days \* 365.
Interventions
- DEVICE Trelegy Ellipta
- DEVICE Stiolto Respimat
- DRUG Tiotropium + Olodaterol (5/5 mcg)
- DRUG Fluticasone Furoate + Umeclidinium + Vilanterol (100/62.5/25 mcg)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9,117 participants |
| Start Date | 2021-12-17 |
| Est. Completion | 2021-12-27 |
What the finished NCT05169424 record still lists
NCT05169424 is an observational study that tracks outcomes without assigning an intervention. Its 9,117 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 4 interventions - of which Trelegy Ellipta is the first listed.
NCT05169424 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05169424 about?
NCT05169424 is a clinical study titled "A Study in the US Based on Pharmacy and Medical Claims That Compares How Well Stiolto® and Trelegy® Work in People With Chronic Obstructive Pulmonary Disease (COPD)". This study looks at data from people with chronic obstructive pulmonary disease (COPD). Some used Stiolto Respimat and the others Trelegy Ellipta as their first treatment for COPD. The purpose of this study is to find out how well the treatments worked. Researchers compare the time to first COPD fl...
What is the current status of trial NCT05169424?
This trial is currently completed. The enrollment target is 9,117 participants. The study started on 2021-12-17. Estimated completion is 2021-12-27.
What interventions are being tested in trial NCT05169424?
The interventions under investigation include: Trelegy Ellipta (DEVICE), Stiolto Respimat (DEVICE), Tiotropium + Olodaterol (5/5 mcg) (DRUG), Fluticasone Furoate + Umeclidinium + Vilanterol (100/62.5/25 mcg) (DRUG).
Who is sponsoring clinical trial NCT05169424?
This trial is sponsored by Boehringer Ingelheim, which has 515 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06946355 · 9,119 participants · NA
Food-based Support for Hospitalized Children and Their Families
- NCT02000089 · 9,000 participants · Phase 3
The Cancer of the Pancreas Screening-5 CAPS5)Study
- NCT05612347 · 8,946 participants · NA
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
- NCT06284408 · 9,460 participants · NA
Centralized Screening Unit (CSU) at Montefiore-Einstein
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI